The vector of anti-MART1 T cell receptor (TCR) is constructed for the engineering of T cell to target Human MART1. The T cells are genetically modified through transduction with a lentiviral vector expressing MART1-specific T cell receptor. And the vector product was designed for the treatment of Melanoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-WFY5527||Anti-MLANA (CBFYM-0653) h(CD28-CD3ζ) CAR, pCDCAR1|
|DMAb-2283-FY||Mouse Anti-MLANA DNA-encoded mAb (CBFYM-2277), pVAX1|
|DMAb-2271-FY||Mouse Anti-MLANA DNA-encoded mAb (CBFYM-0427), pVAX1|
|DMAb-2269-FY||Rabbit Anti-MLANA DNA-encoded mAb (CBFYM-0363), pVAX1|
|CAR-WFY2282||Anti-MLANA (CBFYM-2276) h(41BB-CD3ζ) CAR, pCDCAR1|
|VP-TCR-C298||Lenti-MART-1 (ELAGIGILTV) T cell receptor (DMF5) Viral Particle|
|TCR-C139Z||Human anti-MART1 T cell receptor (SIG35α), pCDTCR1|
|CAR-T-3-M310-2XZ||Anti-MART-1(DMF5) scFv h(CD28-OX40-CD3ζ) CART, pCDCAR1|
|VP-CAR-LC337||Lenti-MART-1(DMF5) CAR (scFv-41BB-CD3ζ, Melan-A) Viral Particle|
|CAR-WFY5526||Anti-MLANA (CBFYM-0432) h(CD28-CD3ζ) CAR, pCDCAR1|
Copyright © 2007 - 2019 Creative Biolabs. All Rights Reserved